Due to studies showing that prolonged exposure to PTH caused osteosarcoma in rat models [33], there has been concern surrounding long-term effects in patients although there is no evidence that patients receiving PTH to treat osteoporosis are of increased risk of developing osteosarcoma [34]. The gene discussed is PTH; the disease is osteoporosis.